IRCT201105291155N13已完成2 期
Ivermectin effect in treatment of patients with human fascioliasis
Vince chancellor for reaserch Guilan univercity of medical sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •persons are over 18 years old with human fascioliasis
- •Exclusion criteria: pregnancy;lactation;hypersensitivy to the drug
排除标准
- 未提供
研究者
相似试验
已完成
1 期
Ivermectine effect in treatment and prophylaxis of patients and exposed idividuals with COVID-19IRCT20200818048444N3Ministry of Health25
招募中
2 期
Effect of ivermectin in COVID-19IRCT20200329046892N3Rasht University of Medical Sciences60
招募中
3 期
Evaluation of the effect of Ivermectin in the treatment of coronavirus infectioIRCT20111224008507N3Mazandaran University of Medical Sciences60
招募中
3 期
Effectiveness of Ivermectin on Outpatient Treatment of Covid-19 PatientsIRCT20210213050344N1Shiraz University of Medical Sciences375
招募中
2 期
Determination the therapeutic effect of Ivermectin and Sovodak on patients infected with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20200408046987N2Akam Tejarat Fartak Farasoo150